2016 American Transplant Congress
Experience of Short-Term Preemptive Treatment for Cytomegalovirus Infection in Seropositive Patients After Liver Transplantation – Ten Years Result of a Single Institution.
Background/purpose Cytomegalovirus (CMV) infection remains a challenge following liver transplantation. Preemptive treatment is an effective strategy for CMV infection. This report shares the ten years'…2016 American Transplant Congress
Transplant Specialized Community Pharmacists' Role in Care Transitions for Transplant Patients.
Purpose:In 2004, the United Network for Organ Sharing (UNOS) bylaws recognized pharmacists as an essential part of the patient care team. Recently, the demand for…2016 American Transplant Congress
Use of the Psychosocial Assessment Tool to Identify Risk in Families of Pediatric Liver Transplant Recipients.
Pediatrics, University of Michigan, Ann Arbor, MI.
Purpose: Although families of pediatric liver transplant recipients have documented psychosocial needs, the systematic identification of needs and delivery of evidence-based care remain challenging. This…2016 American Transplant Congress
Impact of BKV Subtype Distribution on BKV Nephropathy, Viremia, and Renal Outcome in Patients After Renal Transplantation.
Factors determining the course of BK viral (BKV) infection remain uncertain. We studied the role of BKV subtype distribution in BKV-infected patients after renal transplantation.-We…2016 American Transplant Congress
Management of Recurrent aHUS After Adult Kidney transplantation Despite Eculizumab Prophylaxis.
Background Eculizumab (EZB) is approved by NHSE in the UK for prevention and managment of recurrent aHUS after kidney transplantation. Purpose We report aggressive recurrence…2016 American Transplant Congress
Is There a Link Between Proteinuria and Increased FGF-23 Levels in Renal Transplant Patients.
Purpose: Fibroblast growth factor 23 (FGF23) has emerged as a risk factor for cardiovascular disease and mortality in renal transplant (RT) recipients. Post transplantation proteinuria…2016 American Transplant Congress
The Incidence of Symptomatic Pericardial Effusion with Long-Term Sirolimus Therapy.
1Surgery, Albany Medical College, Albany, NY; 2Cardiology, Albany Medical College, Albany, NY.
BACKGROUNDSirolimus is an approved agent for immunosuppressive therapy after renal transplantation. Pericardial effusion and tamponade have been recognized as potentially serious complications of long-term sirolimus…2016 American Transplant Congress
Clinical, Histologic and Charge Endpoints When Populations with Hepatitis C Recurrence Are Treated with Direct-Acting Antiviral or Interferon Based Therapies.
University of Kansas, Kansas City, KS.
Background: While the primary endpoint for patients transplanted for Hepatitis C (HCV) has been established as sustained virologic response (SVR), different pathways have existed to…2016 American Transplant Congress
Real Time Assessment of Kidney Transplant Indication Biopsies by Microarrays: First Results of the INTERCOMEX Study.
1University of Alberta, Edmonton, Canada; 2ATAGC, Edmonton, Canada.
Oncology uses central molecular tissue assessment (MTA) to guide management but the potential of this approach in transplantation is not known. We undertook a prospective…2016 American Transplant Congress
Costimulation Blockade by Anti CD40 Antibody Prevents Humoral and Cellular Rejection of Heterotopic Pig Cardiac Xenograft.
1CSRP/NHLBI, NIH, Bethesda, MD; 2DVR/ORS, NIH, Bethesda, MD; 3Revivicor Inc., Blacksburg, VA.
BackgroundXenotransplantation (XTx) involves the participation of innate immune system with natural antibody producing B cells, NK cells, macrophages and complement as well as adaptive immune…
- « Previous Page
- 1
- …
- 18
- 19
- 20
- 21
- 22
- …
- 180
- Next Page »